11 Sept Programme
Programme
Moderator: Lars Hedbys, Partner, Ventac Partners AB
Venue: Gamla Gästmatsalen, Medicon Village, Scheelevägen 2, Lund
10.00 |
Welcome and Introduction to life science in Medicon Village Ursula Hultkvist Bengtsson, Medicon Village and Christina Bergstrand, UK Trade & Investment
|
10.10 |
Examples of drug development in Lund
- Bioinvent AB (oncology), Cristina Glad, EVP
- Spago Imaging AB (cancer diagnostics and treatment) Åsa Sjöholm Timén, Director, BD
- Tikomed (hematologic cancer, chronic pancreatitis) Adam Bruce, Founder and Board Member
|
10.40
|
NIHR Office for Clinical Research Infrastructure (NOCRI) Ravi Chan, BDM, NOCRI is part of the National Institute for Health Research (NIHR), the UK’s largest public funder of health research. NOCRI can help navigate the clinical research environment and find expert researchers and world class facilities and technologies and support development of collaborative research partnerships. NIHR represent one of the most integrated clinical research systems in the world – driving research from bench to bedside for patient benefit.
Coffee Break
|
11.05
|
From drug discovery – to – manufacturing Short presentations from UK companies (5 MIN)
- Sygnature Discovery, Paul Clewlow
- Pharmaterials Ltd, Chris Landeg
- Almac Group Ltd, Glyn Allsop
- Biotech Services Internationals, Jonathan Lake
- Datatrial, Lewis Baird
- Quotient Bio Research, Andrew Maitland
- Cyprotex Discovery, Daniele Bemporad
- Harlan Laboratories, Joanne Miller
- Sequani Ltd, Laurence Bishop
- Molecular Profiles, Peter Farmer
- Steward Hulse, Venn Life Sciences
- Parexel Ltd, Mathias Ditzen
- Orion Clinical Services Ltd, Peter MacLennan
- A4P Consulting, Carl Watson
- Aptuit, Heidi Pavliska
|
12.25 |
Concluding remarks by Lars Hedbys, Partner, Ventac Partners AB |
12.30 |
Partnering meetings and networking, including lunch |
14.00 |
End of Programme |